期刊文献+

SEREX肿瘤抗原基因表达蛋白的研制和血清学初步筛选 被引量:3

Preparation of SEREX-defined tumor antigens and preliminary study of their sero-reactivity
下载PDF
导出
摘要 目的 :利用基因工程方法获得SEREX肿瘤抗原基因原核表达蛋白 ,为进一步血清学分析奠定基础。方法 :采用SEREX方法 ,筛选中国人卵巢癌cDNA表达文库。对获得的 3个阳性克隆基因MY OVA 2、MY OVA 7和MY OVA 13,利用基因工程的方法克隆其全长基因 ,原核表达和亲和层析获得目的蛋白 ,并采用Dot blot的方法初步检测了目的蛋白抗原在正常人和肿瘤患者中的血清学反应格局。结果 :获得了纯化的目的蛋白 ,采用点杂交对 13例正常人和 74例肿瘤患者血清的测定结果显示 ,MY OVA 13的抗体只在肿瘤组中检测到 ,在正常组中为阴性 ;MY OVA 2和MY OVA 7在两组人群的血清中自身抗体检出率均呈现阳性 ,不同的肿瘤类型的阳性率各不相同。结论 Objective:To obtain tumor antigens for study of the sero activity in sera of normal subjects and tumor patients.Methods:Had cloned MY OVA 2,7 and 13 full length genes and expressed the fusion proteins in E.Coli.The proteins were characterized by SDS PAGE and Western Blot.Using bacterially synthesized and purified proteins,74 patients with different kinds of tumors and 13 healthy controls by dot blot were investigated.Results:Expressed fusion proteins at high level,reaching a yield at least 30% of the total bacteria protein.By using affinity chromatography and thrombin digestion,finally gained three purified proteins,which could be applied to serum screening.Dot blot results showed that auto antibodies against MY OVA 2 and MY OVA 7 were detectable in some of tumor and normal samples,while antibody against MY OVA 13 was only detected in tumor patients(5/74) and not detected in normal subjects(0/13).Conclusion:Tumor antigens prepared from genetic engineering can be adopted for effective seroscreening.
出处 《中国免疫学杂志》 CAS CSCD 北大核心 2002年第2期98-101,共4页 Chinese Journal of Immunology
基金 上海市教委资助项目 上海市科委资助项目 (NoS970 2 0 2和 97XD14 0 0 2 )
关键词 卵巢癌 SEREX筛选 肿瘤抗原 血清学 基因表达 OVA SEREX detection Tumor antigen Serology
  • 引文网络
  • 相关文献

参考文献1

二级参考文献1

共引文献10

同被引文献18

  • 1金姝,王颖,王树军,张惠珍,李美星,陈影,葛海良.CTL识别的HLA-A2限制性人卵巢癌相关抗原OVA66表位的鉴定[J].细胞与分子免疫学杂志,2005,21(2):233-236. 被引量:8
  • 2J萨姆布鲁克 E F 弗里奇 T 曼尼阿蒂斯.分子克隆实验指南[M](第2版)[M].科学出版社,1993.880-898. 被引量:2
  • 3Pardoll D. Does the immune system see tumors as foreign or self[J]. Annu Reu Immunol, 2003,21:807. 被引量:1
  • 4Blattman JN, Greenberg PD. Cancer immnotherapy:A treatment for the masses[J]. Science, 2004,35:200. 被引量:1
  • 5Boyle P. Some recent developments in the epidemiology of colorectal cancer[A]. Bleiberg H,Rougier P,Wilke HJ.Management of colorectal cancer[M].London:Martin Dunitz,1998.19-34. 被引量:1
  • 6Nishikawa H, Tanida K, Ikeda H,et al. Role of SEREX-defined immunogenic wild-type cellular molecules in the development of tumor-specific immunity[J]. Proc Natl Acad Sci USA, 2001, 98(25):14571-14576. 被引量:1
  • 7Chenchik A,Zhu YY,Diatechenko L,et al.Generation and use of high-quality cDNA from small amounts of total RNA by SMARt PCR[A].Siebert PDL. Gene Cloning and Analysis by RT-PCR[M].USA:Biol Techniques Press,1998.305-319. 被引量:1
  • 8Somers VA, Brandwijk RJ, Joosten B, et al.A panel of candidate tumor antigens in colorectal cancer revealed by the serological selection of a phage displayed cDNA expression library[J]. J Immunol,2002,169(5):2772-2780. 被引量:1
  • 9Elbashir SM, Harborth J, Lendeekel W, et al. Duplexs of 21-nuleotide RNA mediate RNA interference in cultured mammalian eells[J]. Nature, 2001,411(6836) :494-498. 被引量:1
  • 10Fire A, Xu S, Montgomery MK, et al. Potent and genetic interference by double-stranded RNA in Cacenorhabditis elegcms[J]. Nature, 1998,391(6669):806-811. 被引量:1

引证文献3

二级引证文献6

;
使用帮助 返回顶部